Overview
SCIENTIFIC SCORE
Questionable
Based on 11 Researches
6.5
USERS' SCORE
Good
Based on 10 Reviews
8.2
Supplement Facts
Serving Size: 1 Capsule
Amount Per Serving
%DV
Vitamin D3 (as cholecalciferol)
125 mcg
625%
Vitamin K activity from:Vitamin K1 (as phytonadione)Vitamin K2 (as menaquinone-4)Vitamin K2 (as trans menaquinone-7)
2,100 mcg1,000 mcg1,000 mcg100 mcg
1,750%
Iodine [from Sea-Iodine™ Complex Blend (organic kelp and bladderwrack extracts, potassium iodide)]
1,000 mcg
667%
Top Medical Research Studies
8
Vitamin D improves heart health
We conducted a double-blind, randomized clinical trial to explore how treating vitamin D deficiency affects heart health, specifically in patients with ischemic heart disease (IHD). In our study, we involved 44 patients aged between 40 and 65 who were dealing with low vitamin D levels. They were divided into two groups—one receiving vitamin D supplements and the other a placebo.
Over five weeks, patients in the intervention group received weekly doses of 50,000 units of vitamin D. We measured changes in their lipid profiles, which includes important markers like cholesterol and triglycerides, as well as C-reactive protein (CRP), an indicator of inflammation.
Our findings revealed that vitamin D supplementation led to significant improvements. Patients in the intervention group showed an increase in good cholesterol (HDL) and a decrease in triglycerides, which are both beneficial for heart health. While the placebo group also experienced some minor improvements, the notable changes were primarily in the group receiving vitamin D.
Overall, these results suggest that addressing vitamin D deficiency can have positive effects on lipid levels in IHD patients. This is an encouraging insight for healthcare providers looking to manage heart disease risk more effectively.
Over five weeks, patients in the intervention group received weekly doses of 50,000 units of vitamin D. We measured changes in their lipid profiles, which includes important markers like cholesterol and triglycerides, as well as C-reactive protein (CRP), an indicator of inflammation.
Our findings revealed that vitamin D supplementation led to significant improvements. Patients in the intervention group showed an increase in good cholesterol (HDL) and a decrease in triglycerides, which are both beneficial for heart health. While the placebo group also experienced some minor improvements, the notable changes were primarily in the group receiving vitamin D.
Overall, these results suggest that addressing vitamin D deficiency can have positive effects on lipid levels in IHD patients. This is an encouraging insight for healthcare providers looking to manage heart disease risk more effectively.
Read More
8
We examined how vitamin D3 could play a role in protecting the heart from damage caused by cisplatin, a chemotherapy drug. In our research, we worked with male Balb-c mice, dividing them into several groups to evaluate different treatment approaches. Some groups received vitamin D3 before or after cisplatin injection, while others acted as controls.
Our findings revealed that cisplatin significantly raised markers indicating heart damage and increased oxidative stress levels. In contrast, when we administered vitamin D3, whether as a preventive measure or treatment after cisplatin exposure, it showed promising results. It was able to improve heart tissue structure and biochemical indicators associated with heart injury, suggesting that vitamin D3 may mitigate some of the cardiac risks linked with chemotherapy.
However, while vitamin D3 showed a protective effect in the groups that received it before cisplatin treatment, the benefits were only partial when given afterward. This highlights the potential of vitamin D3 in supporting heart health during cancer treatment, although more research is necessary to understand its full capabilities and best applications.
Our findings revealed that cisplatin significantly raised markers indicating heart damage and increased oxidative stress levels. In contrast, when we administered vitamin D3, whether as a preventive measure or treatment after cisplatin exposure, it showed promising results. It was able to improve heart tissue structure and biochemical indicators associated with heart injury, suggesting that vitamin D3 may mitigate some of the cardiac risks linked with chemotherapy.
However, while vitamin D3 showed a protective effect in the groups that received it before cisplatin treatment, the benefits were only partial when given afterward. This highlights the potential of vitamin D3 in supporting heart health during cancer treatment, although more research is necessary to understand its full capabilities and best applications.
Read More
4
We investigated how vitamin D3 treatment affects heart disease, particularly focusing on the connection between aortic calcification and cardiac dysfunction. In our study, C57BL/6 mice received daily doses of vitamin D for two weeks, allowing us to observe various factors such as arterial elasticity and cardiac health over an extended period.
As we analyzed the results, we found that vitamin D treatment led to significant aortic calcification and increased pulse propagation velocity. Unfortunately, rather than improving heart function, this treatment correlated with worsened cardiac performance and increased apoptosis, or programmed cell death, among heart cells.
By examining rat heart cells exposed to media from calcified vascular smooth muscle cells, we noticed a similar trend—these conditions caused apoptosis and altered the expression of genes crucial for heart function. Overall, our findings suggest that while vitamin D is often associated with health benefits, in this context, it accelerates cardiac dysfunction through mechanisms like inducing cell death in heart tissues.
These results offer critical insights into the potential dangers of elevated vitamin D levels, particularly in relation to heart health. They highlight the need for further research to better understand these effects and guide treatment strategies for those at risk of heart disease.
As we analyzed the results, we found that vitamin D treatment led to significant aortic calcification and increased pulse propagation velocity. Unfortunately, rather than improving heart function, this treatment correlated with worsened cardiac performance and increased apoptosis, or programmed cell death, among heart cells.
By examining rat heart cells exposed to media from calcified vascular smooth muscle cells, we noticed a similar trend—these conditions caused apoptosis and altered the expression of genes crucial for heart function. Overall, our findings suggest that while vitamin D is often associated with health benefits, in this context, it accelerates cardiac dysfunction through mechanisms like inducing cell death in heart tissues.
These results offer critical insights into the potential dangers of elevated vitamin D levels, particularly in relation to heart health. They highlight the need for further research to better understand these effects and guide treatment strategies for those at risk of heart disease.
Read More
Most Useful Reviews
9
Promotes overall health
9 people found this helpful
Checked, it works. The perfect mix of D and K. I highly recommend it; the price is justifiable. This formulation provides D3 and K in a good dosage—60 capsules last two months for me (I take one daily). It is incomparable to local pharmacy analogues, which are overpriced and ineffective. I'm grateful to Ayherb for these vitamins; they’ve made a significant difference. I feel excellent, taking it with omega and vitamin C. During ARVI, I take a loading dose, which is crucial; you won’t fall ill or it will be mild. I improved this review after we fell ill; everything went smoothly, thanks to this support.
Read More
9
Remarkable health improvement
1 people found this helpful
My husband and I used this Life Extension supplement, and the difference compared to others was remarkable. After further tests, my husband's blood pressure and heart condition have significantly improved! Highly recommend it!
Read More
9
Effective heart health
I’m very pleased with this vitamin D product over the past year in capsule form. The combination with vitamin K is successful, as it transports vitamin D to the organs where it’s most needed. Over nine months, my heart pain has ceased, which previously required medication. It also contains iodine, relevant for my area, and I appreciate that I obtain these vital vitamins in a single capsule! Overall, this product suited me well, and delivery was speedy.
Read More
Medical Researches
SCIENTIFIC SCORE
Questionable
Based on 11 Researches
6.5
- All Researches
8
Vitamin D improves heart health
We conducted a double-blind, randomized clinical trial to explore how treating vitamin D deficiency affects heart health, specifically in patients with ischemic heart disease (IHD). In our study, we involved 44 patients aged between 40 and 65 who were dealing with low vitamin D levels. They were divided into two groups—one receiving vitamin D supplements and the other a placebo.
Over five weeks, patients in the intervention group received weekly doses of 50,000 units of vitamin D. We measured changes in their lipid profiles, which includes important markers like cholesterol and triglycerides, as well as C-reactive protein (CRP), an indicator of inflammation.
Our findings revealed that vitamin D supplementation led to significant improvements. Patients in the intervention group showed an increase in good cholesterol (HDL) and a decrease in triglycerides, which are both beneficial for heart health. While the placebo group also experienced some minor improvements, the notable changes were primarily in the group receiving vitamin D.
Overall, these results suggest that addressing vitamin D deficiency can have positive effects on lipid levels in IHD patients. This is an encouraging insight for healthcare providers looking to manage heart disease risk more effectively.
Over five weeks, patients in the intervention group received weekly doses of 50,000 units of vitamin D. We measured changes in their lipid profiles, which includes important markers like cholesterol and triglycerides, as well as C-reactive protein (CRP), an indicator of inflammation.
Our findings revealed that vitamin D supplementation led to significant improvements. Patients in the intervention group showed an increase in good cholesterol (HDL) and a decrease in triglycerides, which are both beneficial for heart health. While the placebo group also experienced some minor improvements, the notable changes were primarily in the group receiving vitamin D.
Overall, these results suggest that addressing vitamin D deficiency can have positive effects on lipid levels in IHD patients. This is an encouraging insight for healthcare providers looking to manage heart disease risk more effectively.
Read More
8
Vitamin D3 shows potential heart protection
We explored the effects of vitamin D3 and paricalcitol on heart health, particularly in the context of doxorubicin-induced cardiotoxicity. In our study, we worked with male Wistar rats divided into various groups, some receiving doxorubicin, a drug known for its heart-damaging potential. Others were treated with vitamin D3 or paricalcitol, both thought to have protective qualities against heart injury.
After administering doxorubicin, we observed significant changes in a range of biochemical markers and physiological indicators, including ECG readings and scintigraphy results. The findings suggested that both vitamin D3 and paricalcitol demonstrate potential cardioprotective effects by reducing inflammation and oxidative stress linked to heart damage.
This study shines a light on the possible benefits of vitamin D3 in protecting the heart during chemotherapy treatments. However, readers should note that while our findings are promising, they stem from an animal model, and further research is needed to confirm these effects in humans.
After administering doxorubicin, we observed significant changes in a range of biochemical markers and physiological indicators, including ECG readings and scintigraphy results. The findings suggested that both vitamin D3 and paricalcitol demonstrate potential cardioprotective effects by reducing inflammation and oxidative stress linked to heart damage.
This study shines a light on the possible benefits of vitamin D3 in protecting the heart during chemotherapy treatments. However, readers should note that while our findings are promising, they stem from an animal model, and further research is needed to confirm these effects in humans.
Read More
8
We examined how vitamin D3 could play a role in protecting the heart from damage caused by cisplatin, a chemotherapy drug. In our research, we worked with male Balb-c mice, dividing them into several groups to evaluate different treatment approaches. Some groups received vitamin D3 before or after cisplatin injection, while others acted as controls.
Our findings revealed that cisplatin significantly raised markers indicating heart damage and increased oxidative stress levels. In contrast, when we administered vitamin D3, whether as a preventive measure or treatment after cisplatin exposure, it showed promising results. It was able to improve heart tissue structure and biochemical indicators associated with heart injury, suggesting that vitamin D3 may mitigate some of the cardiac risks linked with chemotherapy.
However, while vitamin D3 showed a protective effect in the groups that received it before cisplatin treatment, the benefits were only partial when given afterward. This highlights the potential of vitamin D3 in supporting heart health during cancer treatment, although more research is necessary to understand its full capabilities and best applications.
Our findings revealed that cisplatin significantly raised markers indicating heart damage and increased oxidative stress levels. In contrast, when we administered vitamin D3, whether as a preventive measure or treatment after cisplatin exposure, it showed promising results. It was able to improve heart tissue structure and biochemical indicators associated with heart injury, suggesting that vitamin D3 may mitigate some of the cardiac risks linked with chemotherapy.
However, while vitamin D3 showed a protective effect in the groups that received it before cisplatin treatment, the benefits were only partial when given afterward. This highlights the potential of vitamin D3 in supporting heart health during cancer treatment, although more research is necessary to understand its full capabilities and best applications.
Read More
7
We explored the effects of vitamin D3, a vital nutrient, on heart health, particularly in relation to a common risk factor known as angiotensin II. Our study focused on H9c2 cardiomyoblasts, a type of heart cell, to understand how vitamin D3 interacts with this condition.
By exposing these cells to angiotensin II along with vitamin D3, we aimed to see if the vitamin could shield the cells from damage. Interestingly, we found that vitamin D3 showed significant potential for preventing cell damage when SIRT1, a protein involved in cell survival, was present. However, when we blocked SIRT1, vitamin D3 wasn’t able to protect the heart cells effectively against the harmful effects induced by angiotensin II.
While vitamin D3 did help mitigate some effects of hypertrophy, or heart cell enlargement, it was clear that SIRT1 was crucial for the vitamin's protective benefits. This finding suggests that enhancing SIRT1 activity could be an exciting path forward for developing treatments to combat heart disease linked to hypertrophy and other conditions related to angiotensin II.
By exposing these cells to angiotensin II along with vitamin D3, we aimed to see if the vitamin could shield the cells from damage. Interestingly, we found that vitamin D3 showed significant potential for preventing cell damage when SIRT1, a protein involved in cell survival, was present. However, when we blocked SIRT1, vitamin D3 wasn’t able to protect the heart cells effectively against the harmful effects induced by angiotensin II.
While vitamin D3 did help mitigate some effects of hypertrophy, or heart cell enlargement, it was clear that SIRT1 was crucial for the vitamin's protective benefits. This finding suggests that enhancing SIRT1 activity could be an exciting path forward for developing treatments to combat heart disease linked to hypertrophy and other conditions related to angiotensin II.
Read More
7
We delved into how vitamin D, specifically its receptor activation with ligands like calcitriol, influences heart health when glucocorticoids are involved. Our research showed that glucocorticoids, while effective as immunosuppressants, can harm the musculoskeletal and cardiac systems, leading to significant issues such as falls, fractures, and cardiovascular events in long-term users.
Notably, we discovered that glucocorticoids trigger the expression of certain proteins, known as atrogenes, in bones, muscles, and the heart, which promote protein degradation. However, activating the vitamin D receptor helped prevent this negative response in all three tissues. This protective effect was also supported by the use of carfilzomib, which inhibits the proteasome directly.
Additionally, when we looked at genetic changes alongside glucocorticoid treatment, we noted that mice lacking a specific atrogene, MuRF1, experienced less damage in their skeletal and heart muscles. This suggests that targeting the pathway related to MuRF1 may offer a strategy to cushion the adverse impacts of glucocorticoids on these tissues. Ultimately, our findings highlight vitamin D’s potential role in safeguarding heart and muscle health amidst glucocorticoid treatment.
Notably, we discovered that glucocorticoids trigger the expression of certain proteins, known as atrogenes, in bones, muscles, and the heart, which promote protein degradation. However, activating the vitamin D receptor helped prevent this negative response in all three tissues. This protective effect was also supported by the use of carfilzomib, which inhibits the proteasome directly.
Additionally, when we looked at genetic changes alongside glucocorticoid treatment, we noted that mice lacking a specific atrogene, MuRF1, experienced less damage in their skeletal and heart muscles. This suggests that targeting the pathway related to MuRF1 may offer a strategy to cushion the adverse impacts of glucocorticoids on these tissues. Ultimately, our findings highlight vitamin D’s potential role in safeguarding heart and muscle health amidst glucocorticoid treatment.
Read More
User Reviews
USERS' SCORE
Good
Based on 10 Reviews
8.2
- All Reviews
- Positive Reviews
- Negative Reviews
9
Promotes overall health
9 people found this helpful
Checked, it works. The perfect mix of D and K. I highly recommend it; the price is justifiable. This formulation provides D3 and K in a good dosage—60 capsules last two months for me (I take one daily). It is incomparable to local pharmacy analogues, which are overpriced and ineffective. I'm grateful to Ayherb for these vitamins; they’ve made a significant difference. I feel excellent, taking it with omega and vitamin C. During ARVI, I take a loading dose, which is crucial; you won’t fall ill or it will be mild. I improved this review after we fell ill; everything went smoothly, thanks to this support.
Read More
9
Remarkable health improvement
1 people found this helpful
My husband and I used this Life Extension supplement, and the difference compared to others was remarkable. After further tests, my husband's blood pressure and heart condition have significantly improved! Highly recommend it!
Read More
9
Effective heart health
I’m very pleased with this vitamin D product over the past year in capsule form. The combination with vitamin K is successful, as it transports vitamin D to the organs where it’s most needed. Over nine months, my heart pain has ceased, which previously required medication. It also contains iodine, relevant for my area, and I appreciate that I obtain these vital vitamins in a single capsule! Overall, this product suited me well, and delivery was speedy.
Read More
9
Hormonal balance support
2 people found this helpful
I can't be without it for the second time. I take it to regulate my hormones, and it greatly assists my gland's regularity. Moreover, I had a vitamin D deficiency, making this product essential for me.
Read More
7.5
Improved bone health
2 people found this helpful
The natural composition without unnecessary additives is great. These capsules are easy to take and have no unpleasant aftertaste. After a few weeks, I noticed significant improvement in my bone health and overall well-being. Vitamin D boosted my mood and energy levels, while vitamin K supported heart and blood vessel health. Marine iodine helped regulate my thyroid function, which is another advantage of this natural product.
Read More
Frequently Asked Questions
9
Effective heart health
I’m very pleased with this vitamin D product over the past year in capsule form. The combination with vitamin K is successful, as it transports vitamin D to the organs where it’s most needed. Over nine months, my heart pain has ceased, which previously required medication. It also contains iodine, relevant for my area, and I appreciate that I obtain these vital vitamins in a single capsule! Overall, this product suited me well, and delivery was speedy.
9
Remarkable health improvement
1 people found this helpful
My husband and I used this Life Extension supplement, and the difference compared to others was remarkable. After further tests, my husband's blood pressure and heart condition have significantly improved! Highly recommend it!
7.5
Improved bone health
2 people found this helpful
The natural composition without unnecessary additives is great. These capsules are easy to take and have no unpleasant aftertaste. After a few weeks, I noticed significant improvement in my bone health and overall well-being. Vitamin D boosted my mood and energy levels, while vitamin K supported heart and blood vessel health. Marine iodine helped regulate my thyroid function, which is another advantage of this natural product.
2
Causes discomfort
I've experienced discomfort in my heart after taking these vitamins. Unpleasant feelings followed the start of the regimen. It might be due to the high dosage or possibly that vitamin K does not suit me.
9
Promotes overall health
9 people found this helpful
Checked, it works. The perfect mix of D and K. I highly recommend it; the price is justifiable. This formulation provides D3 and K in a good dosage—60 capsules last two months for me (I take one daily). It is incomparable to local pharmacy analogues, which are overpriced and ineffective. I'm grateful to Ayherb for these vitamins; they’ve made a significant difference. I feel excellent, taking it with omega and vitamin C. During ARVI, I take a loading dose, which is crucial; you won’t fall ill or it will be mild. I improved this review after we fell ill; everything went smoothly, thanks to this support.
7
We explored the effects of vitamin D3, a vital nutrient, on heart health, particularly in relation to a common risk factor known as angiotensin II. Our study focused on H9c2 cardiomyoblasts, a type of heart cell, to understand how vitamin D3 interacts with this condition.
By exposing these cells to angiotensin II along with vitamin D3, we aimed to see if the vitamin could shield the cells from damage. Interestingly, we found that vitamin D3 showed significant potential for preventing cell damage when SIRT1, a protein involved in cell survival, was present. However, when we blocked SIRT1, vitamin D3 wasn’t able to protect the heart cells effectively against the harmful effects induced by angiotensin II.
While vitamin D3 did help mitigate some effects of hypertrophy, or heart cell enlargement, it was clear that SIRT1 was crucial for the vitamin's protective benefits. This finding suggests that enhancing SIRT1 activity could be an exciting path forward for developing treatments to combat heart disease linked to hypertrophy and other conditions related to angiotensin II.
By exposing these cells to angiotensin II along with vitamin D3, we aimed to see if the vitamin could shield the cells from damage. Interestingly, we found that vitamin D3 showed significant potential for preventing cell damage when SIRT1, a protein involved in cell survival, was present. However, when we blocked SIRT1, vitamin D3 wasn’t able to protect the heart cells effectively against the harmful effects induced by angiotensin II.
While vitamin D3 did help mitigate some effects of hypertrophy, or heart cell enlargement, it was clear that SIRT1 was crucial for the vitamin's protective benefits. This finding suggests that enhancing SIRT1 activity could be an exciting path forward for developing treatments to combat heart disease linked to hypertrophy and other conditions related to angiotensin II.
8
Vitamin D improves heart health
We conducted a double-blind, randomized clinical trial to explore how treating vitamin D deficiency affects heart health, specifically in patients with ischemic heart disease (IHD). In our study, we involved 44 patients aged between 40 and 65 who were dealing with low vitamin D levels. They were divided into two groups—one receiving vitamin D supplements and the other a placebo.
Over five weeks, patients in the intervention group received weekly doses of 50,000 units of vitamin D. We measured changes in their lipid profiles, which includes important markers like cholesterol and triglycerides, as well as C-reactive protein (CRP), an indicator of inflammation.
Our findings revealed that vitamin D supplementation led to significant improvements. Patients in the intervention group showed an increase in good cholesterol (HDL) and a decrease in triglycerides, which are both beneficial for heart health. While the placebo group also experienced some minor improvements, the notable changes were primarily in the group receiving vitamin D.
Overall, these results suggest that addressing vitamin D deficiency can have positive effects on lipid levels in IHD patients. This is an encouraging insight for healthcare providers looking to manage heart disease risk more effectively.
Over five weeks, patients in the intervention group received weekly doses of 50,000 units of vitamin D. We measured changes in their lipid profiles, which includes important markers like cholesterol and triglycerides, as well as C-reactive protein (CRP), an indicator of inflammation.
Our findings revealed that vitamin D supplementation led to significant improvements. Patients in the intervention group showed an increase in good cholesterol (HDL) and a decrease in triglycerides, which are both beneficial for heart health. While the placebo group also experienced some minor improvements, the notable changes were primarily in the group receiving vitamin D.
Overall, these results suggest that addressing vitamin D deficiency can have positive effects on lipid levels in IHD patients. This is an encouraging insight for healthcare providers looking to manage heart disease risk more effectively.
7
Vitamin D's limited heart health effects
In our exploration of how vitamin D influences heart health, we conducted a double-blind, randomized controlled trial involving 35 healthy semi-amateur runners. Participants were split into two groups, with one group receiving a hefty dose of 150,000 IU of vitamin D just 24 hours before participating in an ultramarathon, while the other group received a placebo.
After the race, we assessed various biochemical markers related to heart health and iron metabolism. We found that ultramarathon running significantly affected several markers, including cardiac troponin T, which indicates heart stress. Notably, vitamin D supplementation demonstrated a unique interaction with the body’s response to the intense exercise, particularly influencing levels of erythropoietin (EPO) and troponin T.
Although vitamin D showed some effect on heart health markers, especially EPO levels, it did not lead to comprehensive changes in other markers like hepcidin or ferritin. Therefore, while there were hints that vitamin D might help mitigate some heart damage following extreme running, the overall benefits seem limited and specific rather than broad-reaching.
In conclusion, while vitamin D appears to influence certain responses related to heart health during strenuous activity, its role as a protective agent against heart damage in this context remains nuanced and requires further investigation.
After the race, we assessed various biochemical markers related to heart health and iron metabolism. We found that ultramarathon running significantly affected several markers, including cardiac troponin T, which indicates heart stress. Notably, vitamin D supplementation demonstrated a unique interaction with the body’s response to the intense exercise, particularly influencing levels of erythropoietin (EPO) and troponin T.
Although vitamin D showed some effect on heart health markers, especially EPO levels, it did not lead to comprehensive changes in other markers like hepcidin or ferritin. Therefore, while there were hints that vitamin D might help mitigate some heart damage following extreme running, the overall benefits seem limited and specific rather than broad-reaching.
In conclusion, while vitamin D appears to influence certain responses related to heart health during strenuous activity, its role as a protective agent against heart damage in this context remains nuanced and requires further investigation.
4
We investigated how vitamin D3 treatment affects heart disease, particularly focusing on the connection between aortic calcification and cardiac dysfunction. In our study, C57BL/6 mice received daily doses of vitamin D for two weeks, allowing us to observe various factors such as arterial elasticity and cardiac health over an extended period.
As we analyzed the results, we found that vitamin D treatment led to significant aortic calcification and increased pulse propagation velocity. Unfortunately, rather than improving heart function, this treatment correlated with worsened cardiac performance and increased apoptosis, or programmed cell death, among heart cells.
By examining rat heart cells exposed to media from calcified vascular smooth muscle cells, we noticed a similar trend—these conditions caused apoptosis and altered the expression of genes crucial for heart function. Overall, our findings suggest that while vitamin D is often associated with health benefits, in this context, it accelerates cardiac dysfunction through mechanisms like inducing cell death in heart tissues.
These results offer critical insights into the potential dangers of elevated vitamin D levels, particularly in relation to heart health. They highlight the need for further research to better understand these effects and guide treatment strategies for those at risk of heart disease.
As we analyzed the results, we found that vitamin D treatment led to significant aortic calcification and increased pulse propagation velocity. Unfortunately, rather than improving heart function, this treatment correlated with worsened cardiac performance and increased apoptosis, or programmed cell death, among heart cells.
By examining rat heart cells exposed to media from calcified vascular smooth muscle cells, we noticed a similar trend—these conditions caused apoptosis and altered the expression of genes crucial for heart function. Overall, our findings suggest that while vitamin D is often associated with health benefits, in this context, it accelerates cardiac dysfunction through mechanisms like inducing cell death in heart tissues.
These results offer critical insights into the potential dangers of elevated vitamin D levels, particularly in relation to heart health. They highlight the need for further research to better understand these effects and guide treatment strategies for those at risk of heart disease.
References
- Astani A, Maroofi A, Hekmatimoghaddam S, Sarebanhassanabadi M, Safari F. Sirtuin 1 mediates the pro-survival effects of vitamin D in angiotensin II-induced hypertrophy of H9c2 cardiomyoblasts. Mol Biol Rep. 2024;52:96. 10.1007/s11033-024-10168-6
- Sadeghi M, Momeni A, Mirsaeidi FS, Jamalian M, Amirpour A, et al. The Effect of Vitamin D Deficiency Treatment on Lipid Profile and C-reactive Protein in Patients with Ischemic Heart Disease: Double-blind Randomized Clinical Trial. Adv Biomed Res. 2024;13:79. 10.4103/abr.abr_380_23
- Sato AY, Cregor M, McAndrews K, Schurman CA, Schaible E, et al. Pharmacologic or genetic interference with atrogene signaling protects against glucocorticoid-induced musculoskeletal and cardiac disease. JCI Insight. 2024;9. 10.1172/jci.insight.182664
- Stankiewicz B, Mieszkowski J, Kochanowicz A, Brzezińska P, Niespodziński B, et al. Effect of Single High-Dose Vitamin D Supplementation on Post-Ultra Mountain Running Heart Damage and Iron Metabolism Changes: A Double-Blind Randomized Controlled Trial. Nutrients. 2024;16. 10.3390/nu16152479
- Koroglu R, Koroglu M, Aygun H. Electrocardiographic, biochemical, and scintigraphic evidence for the cardioprotective effect of paricalcitol and vitamin D3 on doxorubicin-induced acute cardiotoxicity in rats. Bratisl Lek Listy. 2024;125:281. 10.4149/BLL_2024_42
- Hao N, Yong H, Zhang F, Liu C, Qiu Y, et al. Aortic calcification accelerates cardiac dysfunction via inducing apoptosis of cardiomyocytes. Int J Med Sci. 2024;21:306. 10.7150/ijms.90324
- Samavati I, Ranjbar A, Haddadi R. Cardioprotective effect of vitamin D3 on cisplatin-induced cardiotoxicity in male mice: role of oxidative stress. Naunyn Schmiedebergs Arch Pharmacol. 2024;397:4761. 10.1007/s00210-023-02848-0
- Ogata S, Manson JE, Kang JH, Buring JE, Lee IM, et al. Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease: A Novel Analysis of the VITAL Trial Using Win Ratio and Hierarchical Composite Outcomes. Nutrients. 2023;15. 10.3390/nu15194235
- Arroyo E, Leber CA, Burney HN, Li Y, Li X, et al. Epimeric vitamin D and cardiovascular structure and function in advanced CKD and after kidney transplantation. Nephrol Dial Transplant. 2024;39:264. 10.1093/ndt/gfad168
- Hasific S, Øvrehus KA, Hosbond S, Lambrechtsen J, Kumarathurai P, et al. Effects of vitamins K2 and D3 supplementation in patients with severe coronary artery calcification: a study protocol for a randomised controlled trial. BMJ Open. 2023;13:e073233. 10.1136/bmjopen-2023-073233
- Thompson B, Waterhouse M, English DR, McLeod DS, Armstrong BK, et al. Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial. BMJ. 2023;381:e075230. 10.1136/bmj-2023-075230
